Nov 30, 2023DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care
Since 2007, DaVita has raised millions and impacted thousands globally through annual activity-based events DENVER, Nov. 30, 2023 /PRNewswire/ -- DaVita, a leading provider of kidney care...
Nov 7, 2023
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rodriguez, CEO of DaVita Inc. "We...
Nov 2, 2023DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov....
Oct 17, 2023
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...
Oct 12, 2023
DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...